BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30118965)

  • 21. Somatic genomic imbalances in 'tumour-free' surgical margins of oral cancer.
    Baldan F; Gnan C; Lazarevic M; Nikolic N; Mio C; Tepavcevic Z; Robiony M; Milasin J; Damante G
    Int J Oral Maxillofac Surg; 2023 Aug; 52(8):831-838. PubMed ID: 36639343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
    Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
    Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
    Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
    Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
    Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
    Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas.
    Liu CJ; Lin SC; Chen YJ; Chang KM; Chang KW
    Mol Carcinog; 2006 Oct; 45(10):721-31. PubMed ID: 16676365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological factors involved in local failure in squamous cell carcinoma of the oral cavity: retrospective study and proposal of a new clinical classification.
    Toratani S; Ogawa I; Sasahara H; Yoshioka Y; Kanda T; Tani R; Okamoto T
    Int J Oral Maxillofac Surg; 2019 Feb; 48(2):143-151. PubMed ID: 30190153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: short report.
    Mollaoglu N; Metzler P; Zenk J; Nkenke E; Neukam FW; Ries J
    Cytopathology; 2011 Dec; 22(6):387-91. PubMed ID: 21054590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen Receptor as a Biomarker of Oral Squamous Cell Carcinoma Progression Risk.
    Tomasovic-Loncaric C; Fucic A; Andabak A; Andabak M; Ceppi M; Bruzzone M; Vrdoljak D; Vucicevic-Boras V
    Anticancer Res; 2019 Aug; 39(8):4285-4289. PubMed ID: 31366519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor.
    Gleber-Netto FO; Braakhuis BJ; Triantafyllou A; Takes RP; Kelner N; Rodrigo JP; Strojan P; Vander Poorten V; Rapidis AD; Rinaldo A; Brakenhoff RH; Ferlito A; Kowalski LP
    Oral Oncol; 2015 Aug; 51(8):738-44. PubMed ID: 25987307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of p300 in the tumor progression of oral squamous cell carcinoma.
    Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
    J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
    Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
    Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translational genomics and recent advances in oral squamous cell carcinoma.
    Chai AWY; Lim KP; Cheong SC
    Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
    Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
    J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Evaluation of Tumour--Associated Tissue Eosinophilia and Cyclo-oxegenase-2 Gene in Oral Cancer Patients with Assessment of Long Term Outcomes.
    Rakesh N; Iyengar A; Majumdar K; Vidya GS; Shantha Kumar SS
    Pathol Oncol Res; 2016 Apr; 22(2):385-92. PubMed ID: 26577687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The promising impact of molecular profiling on treatment strategies in oral cancers.
    Foy JP; Saintigny P; Goudot P; Schouman T; Bertolus C
    J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):242-247. PubMed ID: 28576460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
    Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.